Table 2 Comparison of baseline characteristics between the two groups

From: Effectiveness of the intelligent hypertension excellence centers (iHEC) therapy model in the blood pressure management of older hypertensive patients: a randomized controlled trial

Item

Intervention group (n = 261)

Control group (n = 256)

Statistical values

P values

Gender (n,%)

Male

Female

157 (60.2)

104 (39.8)

162 (63.3)

94 (36.7)

0.54

0.46

Nationality (n,%)

Han ethnicity

Minority nationality

225 (86.2)

36 (13.8)

227 (88.7)

29 (11.3)

0.71

0.40

Age (years),mean (SD)

71.6 ± 3.7

71.1 ± 3.8

1.26

0.21

BMI (kg/m2),mean (SD)

24.5 ± 3.3

24.00 ± 3.1

1.62

0.11

Education (n,%)

Junior school and below

136 (52.1)

139 (54.3)

0.25

0.62

Senior school and above

125 (47.9)

117 (45.7)

Marital status (n,%)

Married

191 (73.2)

189 (73.8)

0.03

0.87

Unmarried/divorced/widowed

70 (26.8)

67 (26.2)

  

Current smoking (n,%)

29 (11.1)

31 (12.1)

0.13

0.73

Current alcohol consumption (n,%)

54 (20.7)

47 (18.4)

0.45

0.50

Frailty (n,%)

40 (15.3)

41 (16.0)

0.05

0.83

Types of antihypertensive medication used (n,%)

0

82 (31.4)

79 (30.9)

0.26

0.97

1

66 (25.3)

64 (25.0)

2

88 (33.7)

5 (33.2)

3

25 (9.6)

28 (10.9)

Comorbidity (n,%)

Hyperlipidemia

44 (16.9)

41 (16.0)

0.07

0.80

Diabetes

62 (23.8)

67 (26.2)

0.40

0.53

Asthma/ COPD

49 (18.8)

45 (17.6)

0.12

0.72

Coronary heart disease

9 (3.5)

8 (3.1)

0.04

0.84

Stroke

11 (4.2)

10 (3.9)

0.03

0.86

Heart failure

3 (1.2)

4 (1.6)

0.17

0.68

AF

6 (2.3)

3 (1.6)

0.37

0.54

  1. BMI body mass index, COPD chronic obstructive pulmonary disease, AF atrial fibrillation, SD standard deviation